Influence of Metabolic Dysregulation in the Management of Depressive Disorder—Narrative Review
-
Published:2024-05-29
Issue:11
Volume:16
Page:1665
-
ISSN:2072-6643
-
Container-title:Nutrients
-
language:en
-
Short-container-title:Nutrients
Author:
Jakubowska Paulina1ORCID, Balcerczyk-Lis Marta1, Fortuna Milena1ORCID, Janiak Aleksandra1ORCID, Kopaczyńska Adrianna1ORCID, Skwira Sylwia1ORCID, Młynarska Ewelina1ORCID, Rysz Jacek2, Franczyk Beata1
Affiliation:
1. Department of Nephrocardiology, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland 2. Department of Nephrology, Hypertension and Family Medicine, Medical University of Lodz, ul. Zeromskiego 113, 90-549 Lodz, Poland
Abstract
Depressive disorders are heterogeneous in nature, and their global reach makes them the cause of suffering for a million individuals worldwide. Standard treatment does not work for one in three people, and side effects can significantly reduce the quality of life. A multidisciplinary approach allows for a broader insight into the nature of the disease, given its complex etiology. One of its elements is the hypothesis of inflammation, which also accompanies obesity-related disease. Obesity and depression interact, causing many researchers to develop new non-pharmacological treatment methods for both diseases. One suggestion is physical exercises that have great potential to be used in clinical practice. They can exert changes on the central nervous system and thus modulate mood. Another is diet, which concentrates on active molecules that also affect the central nervous system (CNS). There is an urgent need to create appropriate criteria and recommendations that systematize existing knowledge and allow it to be used in practice. There is an urgent need to create appropriate criteria and recommendations that systematize existing knowledge and allow it to be used in practice.
Reference122 articles.
1. GBD 2017 Disease and Injury Incidence and Prevalence Collaborators (2018). Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 392, 1789–1858. Erratum in Lancet 2019, 393, e44. 2. Cheng, J., Feng, Y., Liu, Z., Zheng, D., Han, H., Liu, N., Liu, S., Zhao, J., Li, X., and Han, S. (2024). Knowledge, attitude, and practice of patients with major depressive disorder on exercise therapy. BMC Public Health, 24. 3. The Prevalence and National Burden of Treatment-Resistant Depression and Major Depressive Disorder in the United States;Zhdanava;J. Clin. Psychiatry,2021 4. Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians;Gartlehner;Ann. Intern. Med.,2023 5. Marasine, N.R., Sankhi, S., Lamichhane, R., Marasini, N.R., and Dangi, N.B. (2021). Use of Antidepressants among Patients Diagnosed with Depression: A Scoping Review. Biomed Res. Int., 2021.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|